CITIZENS FINANCIAL GROUP INC/RI
Position in XENE — Xenon Pharmaceuticals Inc.
CIK 759944
PROVIDENCE, RI
Position in XENE
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$288,598
+$64,498 QoQ
Shares Held
4,963
-0.7% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CITIZENS FINANCIAL GROUP INC/RI holds $30,686,913 across 14 Biotechnology names. XENE ranks #7 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
49,824 | $22,248,408 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,775 | $3,689,356 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
25,822 | $1,668,875 | |
| 4 | ABCL |
AbCellera Biologics Inc.
|
261,890 | $913,996 | |
| 5 | IMNM |
Immunome Inc.
|
19,954 | $436,393 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
4,082 | $303,129 | |
| 7 | XENE |
Xenon Pharmaceuticals Inc.
This page
|
4,963 | $288,598 | |
| 8 | EXEL |
Exelixis, Inc.
|
6,605 | $283,288 |
All Filings in XENE
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $288,598 | 4,963 | Shares | Defined | 2026-05-01 | |
| 2025-12-31 | $224,100 | 5,000 | Shares | Defined | 2026-01-30 | |
| 2025-09-30 | $200,750 | 5,000 | Shares | Defined | 2025-10-24 | |
| No filing history on record for this holder in this stock. | ||||||